- Home
- EMBC vs INNV Comparison
EMBC vs INNV Comparison
Compare EMBC & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMBC
- INNV
- Stock Information
- Founded
- EMBC 1924
- INNV 2007
- Country
- EMBC United States
- INNV United States
- Employees
- EMBC N/A
- INNV N/A
- Industry
- EMBC Medical/Dental Instruments
- INNV Medical/Nursing Services
- Sector
- EMBC Health Care
- INNV Health Care
- Exchange
- EMBC Nasdaq
- INNV Nasdaq
- Market Cap
- EMBC 753.0M
- INNV 817.8M
- IPO Year
- EMBC N/A
- INNV 2021
- Fundamental
- Price
- EMBC $14.62
- INNV $5.26
- Analyst Decision
- EMBC Sell
- INNV Hold
- Analyst Count
- EMBC 1
- INNV 3
- Target Price
- EMBC $12.00
- INNV $6.50
- AVG Volume (30 Days)
- EMBC 247.0K
- INNV 30.0K
- Earning Date
- EMBC 11-26-2024
- INNV 11-05-2024
- Dividend Yield
- EMBC 4.10%
- INNV N/A
- EPS Growth
- EMBC 45.34
- INNV N/A
- EPS
- EMBC 1.20
- INNV N/A
- Revenue
- EMBC $1,118,900,000.00
- INNV $786,512,000.00
- Revenue This Year
- EMBC $1.45
- INNV $13.17
- Revenue Next Year
- EMBC $0.53
- INNV $10.46
- P/E Ratio
- EMBC $12.17
- INNV N/A
- Revenue Growth
- EMBC 0.48
- INNV 12.46
- 52 Week Low
- EMBC $9.93
- INNV $3.52
- 52 Week High
- EMBC $19.79
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- EMBC 48.99
- INNV 34.75
- Support Level
- EMBC $14.81
- INNV $5.80
- Resistance Level
- EMBC $16.19
- INNV $5.94
- Average True Range (ATR)
- EMBC 0.68
- INNV 0.35
- MACD
- EMBC 0.02
- INNV -0.08
- Stochastic Oscillator
- EMBC 27.69
- INNV 6.54
About EMBC Embecta Corp.
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.